How Can the COVID-19 Pandemic Enhance Value-Based Health Care Delivery?

August 12, 2020


Given the constraints prevalent post-COVID-19, Dr Mark Fendrick, director of the University of Michigan Center for Value-Based Insurance Design, stresses that it is now more important than ever for the health care industry to prioritize payment reform, value-based benefit design, and novel policy initiatives.

Is a Mental Health Crisis Emerging in the US Workforce?

August 11, 2020


By increasing access and awareness of mental health services, employers can assist in addressing concerns precipitated by pandemic and racial injustice to curb potentially severe and persistent mental illness, said Joe Grasso, PhD, clinical director of partnerships at Lyra Health.

How Are Employers Addressing Back-to-School, Leave-Related Concerns Amid the Pandemic?

August 08, 2020


Beyond telework, some notable strategies that employers should consider when managing back-to-school and other leave related concerns among employees include child care benefits and flexible work options, said David Weisenfeld, JD, legal editor and host of a XpertHR podcast.

Hinge Health Announces Expansion to Become the First Digital Musculoskeletal Clinic

August 05, 2020


Hinge Health announced the expansion of its clinical and technical musculoskeletal (MSK) capabilities to cover the full continuum of MSK care. The move will provide the most complete back and joint health solution to employers and health plans.

How Can Health Care Purchasers, Providers Better Coordinate to Improve Value-Based Care Delivery?

July 31, 2020


The COVID-19 pandemic spotlighted the lack of preparation and notable disruptions in the US health care delivery system. To optimally transition to delivering high quality and affordable care, findings from a report by the National Alliance of Healthcare Purchaser Coalitions and the Council for Accountable Physician Practices (CAPP) suggest that enhanced care coordination, greater investment in delivery systems and primary care, and aligning reimbursement with patient outcomes is warranted, said Norman Chenven, MD, vice chairman of CAPP.

How Can Telehealth Promote Care Coordination, Value-Based Outcomes in Cardiovascular Disease?

July 29, 2020


Through GoMo Health’s partnership with the Center for Health Technology and Innovation (CHTI) at the American Heart Association (AHA), GoMo, in collaboration with the AHA, has launched the telehealth care coordination solution, known as Concierge Care, a behaviorally-based, patient-centric care solution that can lead to measurable and sustainable population health, said Patrick Dunn, program director of CHTI at the AHA, and Bob Gold, chief executive officer of GoMo Health.

What We're Reading: COVID-19 Vaccine in Phase 3; Employers, Liability Waivers; Flu, Pneumonia Vaccines Reduce Alzheimer Risk

July 27, 2020


In beginning the first phase 3 clinical trial to examine a vaccine candidate for the coronavirus disease 2019 (COVID-19), Moderna Inc announced that the Trump administration increased funding to expand the trial to 30,000 US participants; employers have considered and some have made it a requirement for employees to sign a waiver to not sue the organization if they are infected by COVID-19 or suffered any injury while working; study finds 1 flu shot can reduce the risk for Alzheimer disease by 17% and 1 pneumonia vaccine before age 75 can reduce the risk by 25%.

How Can Integrating Data, Population Health Optimize Employer Health Care Delivery Amid COVID-19?

July 24, 2020


In addressing the COVID-19 pandemic, a more active-based approach is warranted among employers to optimize care. Through detailed databases and a greater focus on population health, Paladina Health has promoted this transition to a more informed, value-based health care delivery system, said Kirk Rosin, chief revenue officer of Paladina Health.

PwC Issues Midyear Deals Report for US Health Services, Global Life Sciences, and Pharmaceutical Sectors

July 23, 2020


In 2 midyear deals reports issued today by PricewaterhouseCoopers (PwC), total US health services deal value and volume were down in the first half (H1) of 2020 compared with H1 2019, with overall global pharma and life sciences sectors also down in H1 2020 compared with the second half of 2019.